SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001005201-20-000035
Filing Date
2020-05-11
Accepted
2020-05-11 10:10:09
Documents
91
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q asrt-331202010q.htm   iXBRL 10-Q 1253264
2 EXHIBIT 31.1 exhibit311-1q2020.htm EX-31.1 13003
3 EXHIBIT 31.2 exhibit312-1q2020.htm EX-31.2 12871
4 EXHIBIT 32.1 exhibit321-1q2020.htm EX-32.1 6992
5 EXHIBIT 32.2 exhibit322-1q2020.htm EX-32.2 7036
  Complete submission text file 0001005201-20-000035.txt   7280480

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asrt-20200331.xsd EX-101.SCH 64890
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT asrt-20200331_cal.xml EX-101.CAL 77027
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT asrt-20200331_def.xml EX-101.DEF 421940
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asrt-20200331_lab.xml EX-101.LAB 716889
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asrt-20200331_pre.xml EX-101.PRE 506082
79 EXTRACTED XBRL INSTANCE DOCUMENT asrt-331202010q_htm.xml XML 1128525
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Filer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13111 | Film No.: 20863050
SIC: 2834 Pharmaceutical Preparations